120 related articles for article (PubMed ID: 6169867)
21. In vitro immune parameters in relation to clinical course in transitional cell carcinoma.
Cummings KB; Kodera Y; Bean MA
Natl Cancer Inst Monogr; 1978 Dec; (49):119-22. PubMed ID: 155220
[TBL] [Abstract][Full Text] [Related]
22. [Light and electron microscopic changes in bladder tumor cells after intravesical instillation and hyperthermic vesical irrigation of bleomycin (author's transl)].
Moriyama N; Ito K
Nihon Hinyokika Gakkai Zasshi; 1980 Nov; 71(11):1371-83. PubMed ID: 6162049
[No Abstract] [Full Text] [Related]
23. [Results of hyperthermia on the bladder carcinomas of the dog (author's transl)].
Rigotti E; Fontana D; Negri GL; Palestro G; Randone DF; Borgno M
J Urol Nephrol (Paris); 1977 Mar; 83(3):175-84. PubMed ID: 853554
[TBL] [Abstract][Full Text] [Related]
24. Cytokines in superficial bladder cancer.
da Silva FC
Acta Urol Belg; 1996 May; 64(2):29-30. PubMed ID: 8701804
[No Abstract] [Full Text] [Related]
25. Effect of hyperthermia on experimental bladder tumors.
Ogura K; Kagawa S; Kurokawa K
Eur Urol; 1981; 7(2):100-4. PubMed ID: 7460999
[TBL] [Abstract][Full Text] [Related]
26. [Hyperthermic perfusion therapy using peplomycin for bladder cancer].
Nakajima K; Hisazumi H; Misaki T; Sugata T; Koshida K; Saito Y; Naito K; Kameda K; Taya T; Miyazaki K
Hinyokika Kiyo; 1985 Sep; 31(9):1559-63. PubMed ID: 2417464
[TBL] [Abstract][Full Text] [Related]
27. Immunotherapeutic strategies for high-risk bladder cancer.
Sharma P; Old LJ; Allison JP
Semin Oncol; 2007 Apr; 34(2):165-72. PubMed ID: 17382800
[TBL] [Abstract][Full Text] [Related]
28. Immunological evaluation of a streptococcal preparation (OK-432) in treatment of bladder carcinoma.
Kagawa S; Ogura K; Kurokawa K; Uyama K
J Urol; 1979 Oct; 122(4):467-70. PubMed ID: 480487
[TBL] [Abstract][Full Text] [Related]
29. Lymphocyte-mediated cytotoxicity in patients with renal and transitional cell carcinoma receiving BCG.
Lange PH
Natl Cancer Inst Monogr; 1978 Dec; (49):343-5. PubMed ID: 748791
[TBL] [Abstract][Full Text] [Related]
30. [Superselective transcatheter embolization for bladder carcinomas (author's transl)].
Nagakura K; Kimura S; Jitsukawa S; Ohsawa A; Tazaki H
Nihon Hinyokika Gakkai Zasshi; 1981 Feb; 72(2):141-50. PubMed ID: 7253349
[No Abstract] [Full Text] [Related]
31. [BCG-instillation therapy in superficial bladder tumor--host immune response elicited by local application of BCG].
Hayakawa M; Hatano T; Saito S; Miyazato T; Nakayama M; Igarashi M; Saita H
Nihon Hinyokika Gakkai Zasshi; 1987 Nov; 78(11):1972-81. PubMed ID: 3502480
[No Abstract] [Full Text] [Related]
32. [PS (peplomycin-silicone) bullet catheter therapy for bladder tumor: combination of hyperthermic treatment and cepharanthine].
Kitajima K; Yoshida T; Okada K; Kishimoto T; Takahashi K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2520-5. PubMed ID: 6210052
[TBL] [Abstract][Full Text] [Related]
33. [Update 2016 - Immunotherapy for urothelial carcinoma].
Retz M; Gschwend JE; Schmid SC
Urologe A; 2016 Feb; 55(2):246-52. PubMed ID: 26767648
[TBL] [Abstract][Full Text] [Related]
34. [Focus on tumor immunology of transitional cell carcinoma].
Olbert PJ; Schrader AJ; Hegele A; Hofmann R
Urologe A; 2007 Sep; 46(9):1135-7. PubMed ID: 17605116
[No Abstract] [Full Text] [Related]
35. [Studies on the cellular immune response in patients with urinary bladder carcinoma. IV. Leukocyte adherence inhibition tests and leukocyte migration inhibition test (author's transl)].
Nishio S; Horii A; Morikawa Y; Kawakita J; Nishijima T; Maekawa M
Nihon Hinyokika Gakkai Zasshi; 1979 Mar; 70(3):305-16. PubMed ID: 374815
[No Abstract] [Full Text] [Related]
36. Treatment of superficial carcinoma of the bladder.
Paulson DF
Prog Clin Biol Res; 1984; 162B():193-209. PubMed ID: 6209720
[No Abstract] [Full Text] [Related]
37. Bladder preserving approach for muscle invasive bladder cancer--role of mycobacterium w.
Chaudhuri P; Mukhopadhyay S
J Indian Med Assoc; 2003 Sep; 101(9):559-60. PubMed ID: 15168998
[TBL] [Abstract][Full Text] [Related]
38. [Experimental studies of effects of the streptococcal anticancer preparation (Picibanil) for bladder carcinomas of ACI/N rats (author's transl)].
Kagawa S
Nihon Hinyokika Gakkai Zasshi; 1976 Feb; 67(2):73-80. PubMed ID: 772265
[No Abstract] [Full Text] [Related]
39. [Cytokine therapy of superficial bladder carcinoma. Mechanisms of action and results of therapy].
Otto T; Kälble T
Urologe A; 1994 Nov; 33(6):540-6. PubMed ID: 7817454
[TBL] [Abstract][Full Text] [Related]
40. Activation by the protein-bound polysaccharide PSK (krestin) of cytotoxic lymphocytes that act on fresh autologous tumor cells and T24 human urinary bladder transitional carcinoma cell line in patients with urinary bladder cancer.
Mizutani Y; Yoshida O
J Urol; 1991 May; 145(5):1082-7. PubMed ID: 2016797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
